Yen‐Ting Lin

Stage Shift Improves Lung Cancer Survival: Real-World Evidence

Ching‐Yao Yang, Yen‐Ting Lin, Li‐Ju Lin et al. · Journal of Thoracic Oncology · 2022 · 86 citations · Full text

Medicine, Oncology, Preventive Medicine +17

Infective endocarditis in children without underlying heart disease

Yen‐Ting Lin, Kai‐Sheng Hsieh, Yao-Shen Chen et al. · Journal of Microbiology Immunology and Infection · 2012 · 70 citations

Medicine, Infectious Diseases, Pediatrics +12

Development of Renal Cysts after Crizotinib Treatment in Advanced ALK-Positive Non–Small-Cell Lung Cancer

Yen‐Ting Lin, Yu‐Fen Wang, James Chih‐Hsin Yang et al. · Journal of Thoracic Oncology · 2014 · 65 citations · Full text

Medicine, Nephrology, Oncology +13

Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first‐line gefitinib, erlotinib and afatinib‐treated non‐small cell lung cancer patients with activating EGFR mutations

Yen‐Ting Lin, Jin‐Shing Chen, Wei‐Yu Liao et al. · International Journal of Cancer · 2018 · 64 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Resistance profiles of anaplastic lymphoma kinase tyrosine kinase inhibitors in advanced non–small-cell lung cancer: a multicenter study using targeted next-generation sequencing

Yen‐Ting Lin, Chi‐Lu Chiang, Jen‐Yu Hung et al. · European Journal of Cancer · 2021 · 44 citations · Full text

Medicine, Oncology, Pharmacology +17